Publications by authors named "David L Graham"

Claim this Profile
E
Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II Trial.
Earle F Burgess, Claud M Grigg, Danielle Boselli, James T Symanowski, AliReza Golshayan, David L Graham

Clin Genitourin Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Pleural Mesothelioma: ASCO Guideline Update.
Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, Quincy Chu, Jane E Churpek, David L Graham

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, David S Mendelson, Thomas J Smith, David L Graham

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Sumanta K Pal, Michael J Miller, Neeraj Agarwal, Susan Marina Chang, Mariana Chavez-MacGregor, David L Graham

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
John Heymach, Lada Krilov, Anthony Alberg, Nancy Baxter, Susan Marina Chang, David L Graham

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Media for Networking, Professional Development, and Patient Engagement.
Merry Jennifer Markham, Danielle Gentile, David L Graham

Am Soc Clin Oncol Educ Book· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine.
Deanna J Attai, Patricia F Anderson, Michael J Fisch, David L Graham, Matthew S Katz

Semin Hematol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of professional social media use in oncology.
Mina S Sedrak, Don S Dizon, Patricia F Anderson, Michael J Fisch, David L Graham

Future Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).
Steven E Schild, Shauna L Hillman, Angelina D Tan, Helen J Ross, William L McGinnis, David L Graham

J Thorac Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social media in cancer care: highlights, challenges & opportunities.
Deanna J Attai, Mina S Sedrak, Matthew S Katz, Michael A Thompson, Patricia F Anderson, David L Graham

Future Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.
Shernan G Holtan, Preston D Steen, Nathan R Foster, Charles Erlichman, Fabiola Medeiros, David L Graham

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Amit M Algotar, M Suzanne Stratton, Frederick R Ahmann, James Ranger-Moore, Raymond B Nagle, David L Graham

Prostate· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ewing's sarcoma: A case report of a 52-year-old woman with recurrent tumor and literature review.
Waseem Khaliq, Mohammad Farshad Bahador, Thomas Nichols Laurence, Ronald Andrew Sapiente, James Sheridan Lewis, David Lee Graham

Oncol Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Anne M Traynor, Ju-Whei Lee, Gerald K Bayer, John M Tate, Sachdev P Thomas, David L Graham

Invest New Drugs· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.
Charles L Loprinzi, Rui Qin, Ernie P Balcueva, Kathleen A Flynn, Kendrith M Rowland, David L Graham

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, Shauna L Hillman, Mark D Hauge, David L Graham

Lung Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Steven E Schild, James A Bonner, Shauna Hillman, Timothy F Kozelsky, Antonio P G Vigliotti, David L Graham

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma-associated solitary epidural amyloidoma of C2-C3 without bony connection or myelopathy: case report and review of the literature.
Carl J Belber, David L Graham

Surg Neurol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
Randolph S Marks, David L Graham, Jeff A Sloan, Shauna Hillman, Steven Fishkoff

Am J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
John C Marsh, Paul Catalano, Jie Huang, David L Graham, Mark J Cornfeld

Clin Colorectal Cancer· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis